PIIIP3 Health Partners Inc.

$10.01

The financials

P3 Health Partners Inc. by the numbers

P3 Health Partners Inc. (PIII) reported revenue of $386M in Q1 2026 (quarter ended March 31, 2026), up 3.5% from the same quarter a year earlier. That came with net income of $1.2M (0.3% of revenue). For the full year FY2025, revenue was $1.46B (−2.8% year on year) and net income −$148M. Its largest product in 2026-Q1 was Capitated at $379M, 95% of the disclosed total, just ahead of Health Care Other at 1.7%.

P3 Health Partners Inc. income statement, Q1 2026 against the same quarter a year earlier
Income statementQ1 2026Q1 2025Change
Revenue$386M$373M+3.5%
Operating income$8.2M−$38Mto a profit
Net income$1.2M−$20Mto a profit
Diluted EPS$0.32−$6.28to a profit
Revenue by product, 2026-Q1, as reported to the SEC
ProductRevenueShare
Capitated$379M95%
Health Care Other$6.9M1.7%
Health Care Patient Service$6.9M1.7%
Health Care Care Coordination Management Fees$6.5M1.6%
Health Care Clinical Fees Insurance$263K0.1%
Health Care Incentive Fees$110K0.0%

Business Segments

Revenue split by product segment, from SEC XBRL filings.

Latest period: Q1 2026Total $400.2M (+13%)
Health Care Incentive Fees grew +424% year on yearHealth Care Clinical Fees Insurance -73% year on year
  • Capitated$379.5MQoQ +11%year on year +2.7%
  • Health Care Other$6.9MQoQ +86%year on year +86%
  • Health Care Patient Service$6.9MQoQ +86%year on year +86%
  • Health Care Care Coordination Management Fees$6.5MQoQ +137%year on year +142%
  • Health Care Clinical Fees Insurance$263.0KQoQ -70%year on year -73%
  • Health Care Incentive Fees$110.0KQoQ +45%year on year +424%
Segment sum = 104% of reported consolidated revenue · Latest source: 10-Q filed 2026-05-14, SEC EDGAR